Patents by Inventor Masahiko Morita
Masahiko Morita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11965510Abstract: A compressor body includes a compression mechanism including a screw rotor that compresses gas, a casing that accommodates the compression mechanism and defines a compression working chambers therein, a suction side bearing that rotatably supports the screw rotor, a bearing chamber that accommodates the suction side bearing, and a liquid supply port that communicates with the compression working chambers and supplies liquid supplied from the outside of the casing into the compression working chambers. The casing has an internal liquid supply flow path that extends from a discharge side of the compression working chambers as an upstream side to a suction side of the compression working chambers as a downstream side and that supplies the liquid to the liquid supply port. The internal liquid supply flow path has a downstream portion reaching the bearing chamber and supplies the liquid to the suction side bearing.Type: GrantFiled: September 28, 2020Date of Patent: April 23, 2024Assignee: Hitachi Industrial Equipment Systems Co., Ltd.Inventors: Shigeyuki Yorikane, Masahiko Takano, Kenji Morita, Yoshitaka Takeuchi
-
Patent number: 11738037Abstract: An object of the invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.Type: GrantFiled: December 30, 2020Date of Patent: August 29, 2023Assignee: KYOWA HAKKO BIO CO., LTD.Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
-
Publication number: 20230263761Abstract: An agent for elevating nitric oxide (NO) concentration comprising glutathione or a salt thereof as an active ingredient; an agent for elevating NO concentration comprising glutathione or a salt thereof as an active ingredient for preventing or ameliorating a vascular endothelial malfunction-related symptom, or dilating blood vessels or promoting blood flow by elevating NO concentration; and a method for elevating NO concentration by ingesting glutathione or a salt thereof.Type: ApplicationFiled: April 11, 2023Publication date: August 24, 2023Applicant: KYOWA HAKKO BIO CO., LTD.Inventors: Masahiko MORITA, Ayako KAMIMURA
-
Publication number: 20230181614Abstract: The invention provides a method for improving attention of a healthy human subject by administering an effective amount of citidine-5?-diphosphocholine or a salt thereof to a healthy human subject.Type: ApplicationFiled: December 21, 2022Publication date: June 15, 2023Applicant: KYOWA HAKKO BIO CO., LTD.Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
-
Patent number: 11654125Abstract: An agent for elevating nitric oxide (NO) concentration comprising glutathione or a salt thereof as an active ingredient; an agent for elevating NO concentration comprising glutathione or a salt thereof as an active ingredient for preventing or ameliorating a vascular endothelial malfunction-related symptom, or dilating blood vessels or promoting blood flow by elevating NO concentration; and a method for elevating NO concentration by ingesting glutathione or a salt thereof.Type: GrantFiled: January 21, 2014Date of Patent: May 23, 2023Assignee: KYOWA HAKKO BIO CO., LTD.Inventors: Masahiko Morita, Ayako Kamimura
-
Patent number: 11583546Abstract: A method of improving both motor function and cognitive function of healthy human subjects through administration of citicoline or its salt in high dosage or low dosage for a period of time, resulting in improved motor function and cognitive function.Type: GrantFiled: April 30, 2015Date of Patent: February 21, 2023Assignee: KYOWA HAKKO BIO CO., LTD.Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
-
Publication number: 20210113601Abstract: An object of the invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.Type: ApplicationFiled: December 30, 2020Publication date: April 22, 2021Applicant: KYOWA HAKKO BIO CO., LTD.Inventors: Kota KUMAGAI, Masahiko MORITA, Takahiro HARA, Kohji FUKUNAGA
-
Patent number: 10905705Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.Type: GrantFiled: October 30, 2013Date of Patent: February 2, 2021Assignee: KYOWA HAKKO BIO CO., LTD.Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
-
Publication number: 20200108034Abstract: The invention provides citrulline or a salt thereof and glutathione or a salt thereof for use in increasing a ratio of muscle mass to total body weight in a person in conjunction with a resistance workout program, as well as a method of increasing a ratio of muscle mass to total body weight in a person by administering citrulline or a salt thereof and glutathione or a salt thereof to the person in conjunction with a resistance workout program. The citrulline and glutathione or salts thereof are administered daily for a period greater than 7 days, whereas the resistance workout program is administered for at least the entire period during which the two compounds are administered. The muscle mass is measured by a body composition meter.Type: ApplicationFiled: May 31, 2018Publication date: April 9, 2020Applicant: KYOWA HAKKO BIO CO., LTD.Inventors: Masahiko MORITA, Ayako KAMIMURA, Darryn S. WILLOUGHBY
-
Patent number: 10369186Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients is provided.Type: GrantFiled: October 30, 2013Date of Patent: August 6, 2019Assignee: KYOWA HAKKO BIO CO., LTD.Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
-
Patent number: 9833426Abstract: An agent for enhancing NO production, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient.Type: GrantFiled: June 28, 2013Date of Patent: December 5, 2017Assignee: Kyowa Hakko Bio Co., Ltd.Inventors: Masahiko Morita, Miho Yin Komatsu, Takahiro Hara
-
Publication number: 20170049796Abstract: A method of improving both motor function and cognitive function of healthy human subjects through administration of citicoline or its salt in high dosage or low dosage for a period of time, resulting in improved motor function and cognitive function.Type: ApplicationFiled: April 30, 2015Publication date: February 23, 2017Applicant: KYOWA HAKKO BIO CO., LTD.Inventors: Deborah Yurgelun-Todd, Perry Renshaw, Miho Takada, Takeshi Ikeda, Masahiko Morita
-
Publication number: 20170042962Abstract: An agent for preventing or ameliorating vascular endothelial malfunction and arteriosclerosis-related symptoms caused by the progress of vascular endothelial malfunction (e.g., ischemic diseases such as myocardial infarction, angina, and peripheral artery occlusion) or low blood flow-related symptoms (e.g., stiff shoulders, excessive sensitivity to cold, swelling, erectile dysfunction, rough skin and decrease in exercise performance due to skeletal muscle hypoactivity), which has an improved NO production enhancing effect is provided. A NO production enhancer comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients.Type: ApplicationFiled: October 26, 2016Publication date: February 16, 2017Inventors: Masahiko Morita, Miho Komatsu, Takahiro Hara
-
Patent number: 9480668Abstract: The present invention provides a blood flow promoting agent containing citrulline or a salt thereof and capsaicin or capsaicinoids as active ingredients, which is safe even by long-term administration, a food with health claims and a functional food affording such action, particularly, a blood flow promoting agent exhibiting an effective vasodilatory action of capsaicin at a low dose free of irritant property, which can be applied to improvement of athletic performance exhibited in relation to peripheral vasodilatation, suppression of fat accumulation, improvement of skin quality, as well as securing blood circulation in ischemic disease and the like, relaxation of blood vessel biased to coarctation due to advancing age, lifestyle-related diseases and the like, prophylaxis of arteriosclerosis, and prophylaxis of stiff neck, feeling of cold, erectile dysfunction, thrombosis and the like due to blood flow disorder.Type: GrantFiled: November 5, 2013Date of Patent: November 1, 2016Assignee: Kyowa Hakko Bio Co., Ltd.Inventors: Masahiko Morita, Ayako Kamimura, Yoshinori Kobayashi
-
Publication number: 20160296586Abstract: An agent for preventing or ameliorating vascular endothelial malfunction and arteriosclerosis-related symptoms caused by the progress of vascular endothelial malfunction (e.g., ischemic diseases such as myocardial infarction, angina, and peripheral artery occlusion) or low blood flow-related symptoms (e.g., stiff shoulders, excessive sensitivity to cold, swelling, erectile dysfunction, rough skin and decrease in exercise performance due to skeletal muscle hypoactivity), which has an improved NO production enhancing effect is provided. A NO production enhancer comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and glutathione or a salt thereof as active ingredients.Type: ApplicationFiled: June 21, 2016Publication date: October 13, 2016Inventors: Masahiko Morita, Miho Komatsu, Takahiro Hara
-
Image recording device that records moving image, method of controlling the same, and storage medium
Patent number: 9420223Abstract: An image recording device capable of obtaining a moving image with less noise even in a low illuminance environment when obtaining a moving image having a wide dynamic range. An image pickup device picks up an image of an object over different exposure time periods to output a plurality of image signals. The plurality of image signals output from the image pickup device are synthesized to thereby obtain a synthesized image. The synthesized image is recorded in a memory at a predetermined frame rate. Respective vertical transfer periods for reading out the plurality of image signals are differentiated according to the different exposure time periods, and the sum of the vertical transfer periods is controlled to a time period defined by the predetermined frame rate.Type: GrantFiled: September 20, 2012Date of Patent: August 16, 2016Assignee: CANON KABUSHIKI KAISHAInventor: Masahiko Morita -
Patent number: 9392954Abstract: A classification estimating system can include an input element group; an intermediate element group into which are input values of first intermediate variables for which a first multiple desensitization, including an accumulation of values of each input element of a first input element group and each value of a first output sensitivity and each value of a first multiplex output sensitivity, has been carried out and calculated; an output element group into which is input a value of an output variable calculated based on a value of each intermediate element of a first intermediate element group and a value of each connection weight; a classification information estimating module for estimating classification information based on pre-stored correspondence relationship information and a value of the output variable; and a classification information display.Type: GrantFiled: January 13, 2012Date of Patent: July 19, 2016Assignee: University of TsukubaInventors: Masahiko Morita, Hiroshi Kawata
-
Publication number: 20150352067Abstract: An agent for elevating nitric oxide (NO) concentration comprising glutathione or a salt thereof as an active ingredient; an agent for elevating NO concentration comprising glutathione or a salt thereof as an active ingredient for preventing or ameliorating a vascular endothelial malfunction-related symptom, or dilating blood vessels or promoting blood flow by elevating NO concentration; and a method for elevating NO concentration by ingesting glutathione or a salt thereof.Type: ApplicationFiled: January 21, 2014Publication date: December 10, 2015Inventors: Masahiko MORITA, Ayako KAMIMURA
-
Publication number: 20150306125Abstract: An objection of the present invention is to provide an agent for preventing or improving decline in brain function such as decreased perception ability, decreased memory learning ability, decreased thinking ability, decreased concentration, decreased attention, decreased judgment ability, depression, and decreased exercise performance caused thereby. According to the present invention, an agent for protecting brain neuronal cells, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients as well as an agent for preventing or improving decline in brain function, comprising citrulline or a salt thereof and citicoline or a salt thereof as active ingredients is provided.Type: ApplicationFiled: October 30, 2013Publication date: October 29, 2015Inventors: Kota Kumagai, Masahiko Morita, Takahiro Hara, Kohji Fukunaga
-
Publication number: 20150297546Abstract: The present invention provides a blood flow promoting agent containing citrulline or a salt thereof and capsaicin or capsaicinoids as active ingredients, which is safe even by long-term administration, a food with health claims and a functional food affording such action, particularly, a blood flow promoting agent exhibiting an effective vasodilatory action of capsaicin at a low dose free of irritant property, which can be applied to improvement of athletic performance exhibited in relation to peripheral vasodilatation, suppression of fat accumulation, improvement of skin quality, as well as securing blood circulation in ischemic disease and the like, relaxation of blood vessel biased to coarctation due to advancing age, lifestyle-related diseases and the like, prophylaxis of arteriosclerosis, and prophylaxis of stiff neck, feeling of cold, erectile dysfunction, thrombosis and the like due to blood flow disorder.Type: ApplicationFiled: November 5, 2013Publication date: October 22, 2015Inventors: Masahiko MORITA, Ayako KAMIMURA, Yoshinori KOBAYASHI